General Information of the Compound
| Compound ID |
CP0329823
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-Acetylfuranonaphthoquinone
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-Acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione
2-Acetylfuranonaphthoquinone
2-Acetylfuro-1,4-naphthoquinone
2-Acetylnaphtho(2,3-b)furan-4,9-dione
2-acetylnaphtho[2,3-b]furan-4,9-dione
83280-65-3
ACN-053294
AKOS027470201
CHEMBL64130
CS-1747
DB12155
DPHUWDIXHNQOSY-UHFFFAOYSA-N
EX-A1314
HY-13919
MolPort-039-101-321
Napabucasin
Napabucasin (BBI608)
Napabucasin (JAN/USAN/INN)
Napabucasin - BBI 608/ FNQ
Napabucasin [USAN:INN]
SCHEMBL1883845
UNII-Z1HHM49K7O
Z1HHM49K7O
ZINC13306865
s7977
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C14H8O4
|
||||||||||||||||||
| Molecular Weight |
240.214
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)c1cc2c(o1)C(=O)c1ccccc1C2=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C14H8O4/c1-7(15)11-6-10-12(16)8-4-2-3-5-9(8)13(17)14(10)18-11/h2-6H,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
DPHUWDIXHNQOSY-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
83280-65-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01503, Signal transducer and activator of transcription 3
Cell Viability or Cytotoxicity Assay
Clinical Information about the Compound
Drug 1 ( Napabucasin )
| Drug Name | Napabucasin | ||
|---|---|---|---|
| Company | Boston Biomedical Cambridge, MA | ||
| Indication | |||
| Target(s) | |||